BioMarin Pharmaceutical is Now Oversold (BMRN)

Apr 3 2014, 11:26am CDT | by

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of BioMarin Pharmaceutical Inc. (NASD: BMRN) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $65.45 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 63.2. A bullish investor could look at BMRN’s 29.6 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of BMRN shares:

Looking at the chart above, BMRN’s low point in its 52 week range is $53.53 per share, with $84.25 as the 52 week high point — that compares with a last trade of $65.60. Find out what 9 other oversold stocks you need to know about »

According to the ETF Finder at ETFChannel.com, BMRN makes up 4.39% of the First Trust NYSE Arca Biotechnology Index Fund ETF (AMEX: FBT) which is trading lower by about 3.5% on the day Thursday.


Special Offer: Find out what Dave Moenning is holding in the ETF Channel Flexible Growth Investment Portfolio with a special 20% off coupon from Forbes and 30 Days Free.
/>/>
 
 
 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Google Self-Driving Cars to Hit Public Roads this Summer
Google Self-Driving Cars to Hit Public Roads this Summer
Google announced today that Google Car prototype vehicles will leave the test track and hit the familiar roads of Mountain View.
 
 
Google Search Analytics Launched in Web Master Tools
Google Search Analytics Launched in Web Master Tools
Google officially announced the new Search Analytics feature in Webmaster tools.
 
 
T-Mobile Hits Verizon with new 'Never Settle Trial' Campaign
T-Mobile Hits Verizon with new 'Never Settle Trial' Campaign
In case customers don't feel satisfied, T-Mobile will pay for them to shift back to Verizon
 
 
SurveyMonkey CEO, Dave Goldberg, Dies at 47
SurveyMonkey CEO, Dave Goldberg, Dies at 47
The cause of his death is still a mystery.